Yamei Chen Selected Research

Yamei Chen Research Topics

Disease

20	Neoplasms (Cancer) 10/2023 - 08/2013
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023 - 10/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 06/2018
3	Cardiac Arrhythmias (Arrythmia) 06/2015 - 01/2011
2	Disease Progression 11/2021 - 06/2018
2	Carcinogenesis 10/2020 - 03/2014
2	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 03/2014
1	Hypoxia (Hypoxemia) 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	beta-Thalassemia (Cooley's Anemia) 01/2023
1	Thalassemia 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021
1	Esophageal Squamous Cell Carcinoma 11/2021
1	Gingivitis 04/2021
1	Lung Injury 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Chromosomal Instability (Chromosome Stability) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Heart Failure 08/2014
1	Bruton type agammaglobulinemia 01/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2014
1	Cytokine Release Syndrome 01/2014
1	Leukemia 01/2014
1	Glioma (Gliomas) 01/2014
1	Tumor Lysis Syndrome 01/2014
1	Infarction (Infarctions) 06/2013
1	Ischemia 06/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2013
1	Primary Myelofibrosis (Myelosclerosis) 06/2012
1	Acute Promyelocytic Leukemia 06/2012

Drug/Important Bio-Agent (IBA)

3	bisphenol AIBA 06/2013 - 01/2011
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 11/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 04/2022
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2014
2	phenethyl isothiocyanate (PEITC)IBA 05/2016 - 03/2014
2	AndrogensIBA 05/2016 - 03/2014
2	ibrutinibIBA 01/2014 - 08/2013
1	Ligases (Synthetase)IBA 10/2023
1	MTOR InhibitorsIBA 10/2023
1	ruxolitinibIBA 01/2023
1	AntigensIBA 01/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	3' Untranslated Regions (3' UTR)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Competitive Endogenous RNAIBA 11/2021
1	Dentifrices (Dentifrice)IBA 04/2021
1	Sodium Fluoride (Ossin)FDA Link 04/2021
1	FluoridesIBA 04/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2021
1	pirfenidoneIBA 01/2021
1	CollagenIBA 01/2021
1	Coloring Agents (Dyes)IBA 10/2020
1	LigandsIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	GlutaminaseIBA 01/2020
1	Aurora Kinase AIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 06/2018
1	CrizotinibIBA 06/2018
1	Hormones (Hormone)IBA 05/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2016
1	CatecholaminesIBA 06/2015
1	Chloride-Bicarbonate AntiportersIBA 08/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2014
1	IsothiocyanatesIBA 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Phosphotransferases (Kinase)IBA 08/2013
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 08/2013
1	Agammaglobulinaemia Tyrosine KinaseIBA 08/2013
1	EnzymesIBA 08/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2013
1	Estrogens (Estrogen)FDA Link 06/2013
1	DNA Methyltransferase 3AIBA 01/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2012
1	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2012
1	Arsenic Trioxide (Trisenox)FDA Link 06/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2012
1	CalciumIBA 01/2011

Therapy/Procedure

5	Therapeutics 10/2023 - 06/2012
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2014
2	Chemoradiotherapy 10/2021 - 10/2021
2	Radiotherapy 04/2021 - 01/2021
1	Stem Cell Transplantation 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Immunotherapy 11/2021
1	Aftercare (After-Treatment) 05/2016